REVITALIST LIFESTYLE WLNS - RVLWF STOCK NEWS

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has announced that CEO Kathryn Walker will speak at the prestigious Wonderland conference on November 8, 2021, in Miami. The event focuses on psychedelic medicine, addressing the urgent need for psychedelic-assisted psychotherapy clinics amid a growing mental health crisis, estimated to cost US$16 trillion. Walker emphasizes the importance of collaboration post-COVID-19 to tackle mental health issues. The event gathers industry leaders, researchers, and investors to foster dialogue and innovation in psychedelic treatments.

Revitalist Lifestyle and Wellness Ltd. has announced its eligibility for Depository Trust Company (DTC) services, enhancing trading access for U.S. investors under the ticker RVLWF. CEO Kathryn Walker expressed enthusiasm about this milestone, which aims to broaden investor access and liquidity in the U.S. market. The DTC facilitates electronic clearing and settlement, easing stock trading processes. Revitalist operates five clinics across the U.S. and is committed to improving wellness through innovative treatment options.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has signed a binding letter of intent on October 25, 2021, to acquire a ketamine clinic in Jacksonville, Florida, marking its eighth clinic in five states. The clinic, established in 2017 and managed by Dr. Nicholas Kalynych, specializes in ketamine infusion treatments for mood disorders and chronic pain syndromes. The acquisition, estimated at $100,000, will be partly funded by shares and cash. With this move, Revitalist aims to enhance its brand visibility and healthcare services, especially for the local veteran community.

Revitalist Lifestyle and Wellness Ltd. has announced a new lease for a location in Powell, Tennessee, extending its operational footprint. The lease covers 3,500 square feet initially, with an option for an additional 4,500 square feet, potentially increasing total revenue capacity from approximately $3.55 million to $7.1 million annually. This expansion reflects the company's growth since establishing its first clinic in the area in 2018, driven by high demand for its wellness services.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM; OTC: RVLWF) announced that Clarus Securities Inc. has published an initial research report on the company. This report and any future publications can be directly accessed through Clarus. Revitalist clarifies that the opinions and forecasts provided by Clarus are solely those of the firm and do not reflect the views of Revitalist or its management. The company operates five clinics across the U.S., specializing in wellness services for treatment-resistant conditions and lifestyle optimization.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has announced the launch of intensive outpatient programs (IOP) to enhance patient care. Starting on November 1, 2021, at their Chattanooga clinic, IOP will offer support for patients completing ketamine-assisted psychotherapy (KAP). The program includes three weekly sessions over six weeks at an approximate cost of USD $4,300, eligible for insurance reimbursement. The outpatient mental health industry is projected to grow to USD $34 billion by 2025.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF, FSE: 4DO) has commenced trading on the Frankfurt Stock Exchange (FSE), expanding its presence beyond Canada. This cross-listing aims to enhance liquidity and broaden its investor base in Europe. CEO Kathryn Walker emphasized the importance of this milestone in connecting with international investors. Revitalist has five clinics in the United States, offering comprehensive care, lifestyle optimization services, and over 7,000 treatments for patients with treatment-resistant conditions since 2018.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) announced its clinics will now collaborate with psychiatric physicians to provide transcranial magnetic stimulation (TMS). This initiative enhances access to insurance-covered TMS care, broadening market share. TMS is a noninvasive treatment for conditions like depression and Alzheimer’s. The global TMS market is projected to grow from USD 962.5 million in 2020 to USD 1.614 billion by 2026 at a 9% CAGR. CEO Kathryn Walker emphasizes the mutual benefits of this arrangement for patients, physicians, and revenue potential.

Revitalist Lifestyle and Wellness Ltd. has announced a non-binding letter of intent to acquire a ketamine clinic in Richmond, Virginia, for an estimated total consideration of $1,000,000. Payment will consist of $750,000 in common shares, $50,000 in cash, and the assumption of $250,000 in debt. Founded in 2019, the clinic treats various mood disorders and chronic pain conditions, having administered over 1,500 infusions. Dr. Randy Frederick will continue managing the clinic, aiming to expand Revitalist's operations across the U.S.